Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × cemiplimab × CNS × Clear all

Phase

Status

Terminated 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 19 Dermatologic 13 Genitourinary 10 Head & Neck 8 Gastrointestinal 7 Gynecologic 5 Other solid neoplasm 4 Lymphoid 4 Breast 4 Sarcoma 3 Endocrine 3 Tumor-Agnostic 2 Plasma cell 2 Other hematologic neoplasm 1 Other 1 Myeloid 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Temozolomide 67 Magnetic Resonance Spectroscopy 61 Radiotherapy 41 Specimen Handling 39 Radiosurgery 31 Bevacizumab 23 Cyclophosphamide 22 pembrolizumab 20 Radiation 18 Blood Specimen Collection 14 fludarabine 12 Lomustine 12 Irinotecan 12 Pemetrexed 11 Nivolumab 11 Etoposide 10 Carboplatin 10 Biopsy 10 Vincristine 9 Surgical Procedures, Operative 9 trametinib 8 lutetium Lu 177 dotatate 8 Ipilimumab 8 Fluorodeoxyglucose F18 8 naxitamab 7 fluciclovine F-18 7 Proton Therapy 7 Everolimus 7 Drug Therapy 7 olaparib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05317858 2025-12-10

LIMITLESS

InSightec

Phase 3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡